Looking ahead to 2024

Looking ahead to 2024

This hasn’t exactly been a great year when it comes to investing in diabetes tech – insulin pump market leader Insulet s down almost 30% on a year to date basis – Dexcom is UP a little over 9% YTD – but get a load of these year to date stats – Tandem down over 40% - Senseonics down almost 40% -Embecta down almost 30% and the winner for the largest year to date percentage drop is that shame of a CGM company known as Nemaura Medical down over 90%. Just in case anyone is curious Abbott is down about 2% for the year . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.